BARCLAYS PLC - MAXCYTE INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of MAXCYTE INC
ValueSharesWeighting
Q3 2023$98
-38.4%
31,565
-9.6%
0.00%
Q2 2023$159
-58.8%
34,924
-55.2%
0.00%
Q1 2023$386
+132.5%
77,878
+154.5%
0.00%
Q4 2022$166
-99.8%
30,597
+172.7%
0.00%
Q3 2022$72,000
+18.0%
11,220
-12.3%
0.00%
Q2 2022$61,000
-73.8%
12,792
-61.5%
0.00%
Q1 2022$233,000
+870.8%
33,229
+1296.2%
0.00%
Q4 2021$24,000
+60.0%
2,380
+95.2%
0.00%
Q3 2021$15,0001,2190.00%
Other shareholders
MAXCYTE INC shareholders Q4 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,225,000$20,963,0008.46%
NORTH RUN CAPITAL, LP 556,960$3,620,0007.35%
Vitruvian Partners LLP 5,043,356$32,782,0005.85%
Casdin Capital, LLC 10,735,786$69,783,0004.58%
RIVER GLOBAL INVESTORS LLP 1,867,113$11,880,0002.28%
APIS CAPITAL ADVISORS, LLC 200,000$1,300,0001.95%
Pier Capital, LLC 1,262,654$8,207,0001.41%
Montanaro Asset Management Ltd 929,000$6,009,0000.92%
First Light Asset Management, LLC 1,362,543$8,857,0000.90%
Grandeur Peak Global Advisors, LLC 1,206,013$7,839,0000.48%
View complete list of MAXCYTE INC shareholders